Inception- 2016

Location- Bengaluru

Domain- Medtech

Founders- Dr Subhasis Sarangi

Total team strength- NA

Total funds raised- NA

Investors- Received grants and investments from Govt and private organizations

Revenue generated since inception- NA

Key highlights- 

• Aims for bringing innovative solutions for cancer staging, screening, localization, imaging, and hyperthermia
• The idea is to use magnetic nanotechnology to remove the need for radioactivity and strong chemicals for cancer treatment
• The first product MafPro is an ultrasensitive hand-held magnetic probe system for staging and localization of breast, uterine, head & neck, and colorectal cancer
• The second product MafCyto is a novel magnetic blood filtration system to help treat cytokine release syndrome, a life-threatening condition in cancer, sepsis, and COVID-19 patients
• SIAMAF has received BIRAC BIG grant, Longitude Prize Discovery Award, Idea2PoC Grant, Star Startup Award, and Elevate 100 Award
• The company has established a solid IP base through filing several national and international patents on magnetic nanotechnology
• Targeting to be a 1-Billion-dollar company

Founder Speaks-

"There is a huge opportunity for the healthcare and medical device sectors in India. The sheer population of the country has a large existing and unmet needs in healthcare. The role of the Govt is key in promoting startups and existing companies in the healthcare space with adequate funds, nurturing and growing them with good policies. If well supported, then there is a good possibility to reduce imports and can be seen as a very good example for Atmanirbhar."

- Dr Subhasis Sarangi, Founder, SIAMAF Healthcare Pvt Ltd, Bengaluru